InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels

Cancer/ Palliative treatment
Miura et al.
Used Parameters : SMM

Publication Year : 2015

Country : Japan

Journal : Pancreas

Objectives High serum level of interleukin 6 (IL-6) is associated with high degree of tumor progression and systemic weakness. Anti–IL-6 therapy possibly improves the deterioration of clinical characteristics in patients with high IL-6 level. However, IL-6–related factors in patients with treatment-naive advanced pancreatic cancer (PC) have not been established. The goal of this study was to identify IL-6–related factors in patients with advanced PC who were scheduled to undergo first-line chemotherapy.
Full text